TM

Inference & Quantification Engine

The most complicated of problems deserve the most sophisticated of solutions.

Introducing IQ, only the first iteration of our award winning AI engine, and the end-goal for the rest of the industry.

data fuSion

IQ  is being developed to seamlessly performing multimodal analyses, combining information from sources such as medical images, patient records, genomics profiles and fluid biomarkers to generate powerful hyper parameters that act as the signatures of pathological processes, allowing it to perform highly accurate disease diagnosis, stratification, staging, and outcome prognosis.   

Strength in numBers

The current alpha release of IQ delivers extreme performance across a range of diagnostics tasks. Here’s how it compares to volumetric-based methods in initial tests, for tasks such as dementia diagnosis, stratification, staging and prognosis, using only the imaging data provided by the ADNI 1 & 2 studies.

Diagnosis

Healthy-Aged 

vs 

Alzheimer's

AINOSTICS

Volumetric

95%

86%

Healthy-Aged 

vs 

MCIs

AINOSTICS

Volumetric

93%

77%

Stratification

MCIs

vs

Alzheimer's

AINOSTICS

Volumetric

92%

75%

Staging

Early MCIs 

vs

Late MCIs

AINOSTICS

Volumetric

91%

52%

Prognosis

Converting MCIs

vs

Stable MCIs

AINOSTICS

Volumetric

88%

48%

We are working to further validate these results and to reproduce them in data from larger cohorts of normal and patient populations.

  • White LinkedIn Icon
  • White Twitter Icon
  • Email-PNG-Pic-Recovered

 

 LONDON          MANCHESTER          BEIJING          SAN FRANCISCO 

AINOSTICS, IQ, AIN and their respective logos are trademarks of AINOSTICS Ltd in numerous territories.
 

AINOSTICS © 2020. All rights reserved | AINOSTICS Limited is a company registered in England. | Company Registration No. 11420367 | Privacy Statement